RF26 | PMON335 Once-Weekly Somapacitan Versus Daily Growth Hormone in Children Born Small for Gestational Age: Results From a Randomized Phase 2 Trial

Treatment of persistent short stature in children born small for gestational age (SGA) requires daily growth hormone (GH) injections that can be burdensome for patients and caregivers. Once-weekly somapacitan is a long-acting GH currently in phase 3 development for replacement therapy in children wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Juul, Anders, Backeljauw, Philippe, Højby, Michael, Kawai, Masanobu, Kildemoes, Rasmus Juul, Linglart, Agnès, Zuckerman-Levin, Nehama, Horikawa, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625742/
http://dx.doi.org/10.1210/jendso/bvac150.1336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625742/
http://dx.doi.org/10.1210/jendso/bvac150.1336

Ejemplares similares